Treating Opioid Use Disorder on the Inpatient Psychiatric Unit: A Novel Buprenorphine Consultation Service

Treating Opioid Use Disorder on the Inpatient Psychiatric Unit: A Novel Buprenorphine Consultation Service

<b>Background:</b> Opioid Use Disorder (OUD) has claimed the lives of many Americans, with rates of overdose steadily rising over the past decade. Despite having highly effective medications to treat this condition, many providers still hesitate to prescribe them. Psychiatric inpatient f...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sean T. Lynch, Victor Gordillo, Ashley Sacks, Emily Groenendaal, Lidia Klepacz, Eldene Towey, Stephen J. Ferrando
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Pharmacoepidemiology
Subjects:	opioid use disorder buprenorphine co-occurring disorders addiction consultation inpatient psychiatry
Online Access:	https://www.mdpi.com/2813-0618/4/2/11
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01)

Breaking barriers: Assessing the feasibility and acceptability of telemedicine-assisted buprenorphine induction for opioid use disorder in India
by: Abhishek Ghosh, et al.
Published: (2024-10-01)

Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
by: Kathleen K. Adams, et al.
Published: (2025-02-01)

Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01)

Ketamine treatment for buprenorphine-precipitated opioid withdrawal: a case report
by: Ezioma Gbujie, et al.
Published: (2025-06-01)

Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl
by: Bradley D. Stein, et al.
Published: (2025-04-01)

Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
by: Laura B. Monico, et al.
Published: (2025-02-01)

Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis
by: Aline Lott, et al.
Published: (2025-04-01)

Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
by: Kevin Y. Xu, et al.
Published: (2025-01-01)

Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
by: Margarita Popova, et al.
Published: (2024-12-01)

Comparing quality of life methadone and buprenorphine for opioid substitution treatment in Iran
by: Ahmad Nemati, et al.
Published: (2025-08-01)

Advancing emergency department–initiated buprenorphine
by: Kristen Huntley, et al.
Published: (2021-06-01)

Emergency department‐initiated buprenorphine protocols: A national evaluation
by: Clara Z. Guo, et al.
Published: (2021-12-01)

Patient acceptance of emergency department-initiated buprenorphine and reasons for declining
by: Lindsey K. Jennings, et al.
Published: (2025-03-01)

Outpatient-based buprenorphine-assisted opioid withdrawal management: A preliminary prospective observational study
by: Avinash Jhajharia, et al.
Published: (2025-04-01)

Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder
by: Marlene C. Lira, et al.
Published: (2025-02-01)

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
by: Pouya Azar, et al.
Published: (2025-05-01)

Age and racial and ethnic disparities in filled buprenorphine prescriptions post‐emergency department visit in Nevada
by: Olufemi Ajumobi, et al.
Published: (2024-10-01)

Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
by: Arash Mansoori, et al.
Published: (2025-04-01)

Emergency department management of opioid use disorder in pediatric patients
by: Evan S. Schwarz, et al.
Published: (2024-10-01)

Is buprenorphine use in pregnancy linked to decreased fetal breathing movement
by: Caroline M. Bulger, et al.
Published: (2025-05-01)

Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01)

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study
by: Melissa Davoust, et al.
Published: (2025-03-01)

First, Do No Harm: Buprenorphine Use for Pain Associated with Chronic Diseases
by: Amanda Springer, et al.
Published: (2024-11-01)

Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California
by: Yun Wang, et al.
Published: (2025-08-01)

An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada
by: Aleksandra M. Zuk, et al.
Published: (2024-12-01)

Characterizing withdrawal from long-acting injectable buprenorphine: An observational case series
by: Victoria Hayes, et al.
Published: (2025-06-01)

Barriers and facilitators to prescribing buprenorphine for treating opioid use disorder among emergency department and other practice setting physicians
by: James A. Swartz, et al.
Published: (2025-01-01)

Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
by: Jamshid Ahmadi, et al.
Published: (2020-01-01)

Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
by: Mateusz Szczupak, et al.
Published: (2025-04-01)

Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trial
by: Cari Coles, et al.
Published: (2025-06-01)

Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists
by: Li-Tzy Wu, et al.
Published: (2024-12-01)

Expanding buprenorphine prescribing in primary care: a qualitative study of the experiences of primary care providers and nurse care managers participating in the New York City buprenorphine nurse care manager initiative
by: Elodie C. Warren, et al.
Published: (2025-08-01)

Psychosocial Correlates of Insomnia Symptoms Among Women and Men Receiving Buprenorphine Treatment for Opioid Use Disorder
by: Sajanee Chithranjan, et al.
Published: (2025-05-01)

Consultation-Liaison Psychiatry: A Step toward Achieving Effective Mental Health Care for Medically Ill Patients
by: Siddharth Sarkar, et al.
Published: (2021-01-01)

Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study
by: Joel Sprunger, et al.
Published: (2024-12-01)

Case report: Local anesthesia with lidocaine infiltration for extended-release buprenorphine therapy
by: Pouya Azar, et al.
Published: (2025-01-01)

Investigation of Consultations Requested by Dermatology Inpatient
by: Dağdaş AD, et al.
Published: (2025-01-01)

Quality of life of treated opiate addicts in the methadone maintenance program and those treated with buprenorphine
by: Marinković Mirjana, et al.
Published: (2017-01-01)

mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with methamphetamine use and opioid use disorder
by: Elenore P. Bhatraju, et al.
Published: (2025-01-01)